Biosimilar Market Share, Size, Growth,
Analysis, Trends & Forecast to 2022: Radiant
Insights, Inc
“As per RNCOS report "Global Biosimilar Market
Outlook 2022", the global biosimilars market is
anticipated to witness a high double digit growth
during 2016-2022.”
A biosimilar is a biologic product that is similar to a regulatory body approved reference product,
and has no clinically meaningful differences in terms of safety and effectiveness from that
reference product. Only minor differences in clinically inactive components are allowable in
biosimilar products. The global biosimilars market is expected to witness a steep growth owing to
the patent expiry of blockbuster biologic drugs. The ability of biosimilars to reduce healthcare costs
is another driving factor for this industry. Furthermore, the recent approval of three biosimilars in
the US market is providing an impetus to more biopharmaceutical companies to enter this field.
As per RNCOS report "Global Biosimilar Market Outlook 2022", the global biosimilars market is
anticipated to witness a high double digit growth during 2016-2022. This report provides a detailed
analysis of the current and future market scenario of the global biosimilars market. The report
provides insight about the major drivers and challenges, along with the latest trends and
developments impacting the industry growth. In addition, the report also highlights various
opportunities available for growth of the global biosimilars market.
To Get Full Report Click Here @ http://www.radiantinsights.com/research/global-
biosimilar-market-outlook-2022
Follow Us: